Related Experiment Video
Updated: May 6, 2026

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method
Published on: September 10, 2017
Overexpression of DRAM enhances p53-dependent apoptosis
Masahiro Takahashi1, Yuichi Kakudo, Shin Takahashi
1Department of Clinical Oncology, Institute of Development, Aging and Cancer, Tohoku University , 4-1 Seiryo-machi, Aoba-ku, Sendai, Japan.
Abstract:
Tumor suppressor p53-dependent apoptosis is thought to be one of the most important tumor-suppressive mechanisms in human tumorigenesis. Till date, "super p53" mutants exhibiting more potent ability to induce apoptosis than wild-type p53 have been reported. These super p53s may provide a clue for development of novel therapeutic targets. However, the major mechanism underlying the super p53-dependent apoptosis remains unclear. To identify critical gene(s) in this mechanism, we performed a comprehensive and comparative expression analysis in p53-null Saos-2 cells with conditional expression of wild-type p53 and S121F, which was previously reported as a super p53 mutant. We identified damage-regulated autophagy modulator (DRAM) as one of the genes that were more upregulated by S121F than wild-type p53. Although knockdown of DRAM was not sufficient for reducing the ability of S121F to induce apoptosis, DRAM overexpression enhanced the ability in a wild-type p53-dependent manner. Here, we show that DRAM is an important gene for the enhancement of p53-dependent apoptosis. Additional analysis of the mechanism of super p53-dependent apoptosis may lead to the identification of novel drug targets for cancer therapy.
Insights
Super p53 mutants enhance tumor suppression through increased apoptosis. Researchers identified damage-regulated autophagy modulator (DRAM) as a key gene involved in this enhanced p53-dependent apoptosis, offering potential cancer therapy targets.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Death Mechanisms
Background:
- Tumor suppressor p53-dependent apoptosis is crucial for preventing human tumorigenesis.
- "Super p53" mutants show enhanced apoptotic activity compared to wild-type p53.
- The precise mechanisms driving super p53-mediated apoptosis remain largely unknown.
Purpose of the Study:
- To identify critical genes involved in the enhanced apoptosis induced by super p53 mutants.
- To elucidate the role of identified genes in the context of wild-type and mutant p53 activity.
- To explore potential novel therapeutic targets for cancer treatment based on these mechanisms.
Main Methods:
- Comparative gene expression analysis was performed in p53-null Saos-2 cells.
- Conditional expression of wild-type p53 and the 'super p53' mutant S121F was utilized.
- Gene knockdown and overexpression experiments were conducted to assess functional roles.
Main Results:
- Damage-regulated autophagy modulator (DRAM) was identified as significantly upregulated by the S121F mutant compared to wild-type p53.
- DRAM overexpression enhanced p53-dependent apoptosis in a manner dependent on wild-type p53.
- While DRAM knockdown did not abolish S121F-induced apoptosis, its overexpression potentiated the effect.
Conclusions:
- Damage-regulated autophagy modulator (DRAM) plays an important role in potentiating p53-dependent apoptosis.
- The findings highlight DRAM as a key player in the mechanism of super p53-mediated tumor suppression.
- Further investigation into super p53 mechanisms may reveal novel therapeutic strategies for cancer.
Related Concept Videos
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Negative Regulator Molecules

